144 related articles for article (PubMed ID: 18832525)
1. Linkage of Crohn's disease-related serological phenotypes: NFKB1 haplotypes are associated with anti-CBir1 and ASCA, and show reduced NF-kappaB activation.
Takedatsu H; Taylor KD; Mei L; McGovern DP; Landers CJ; Gonsky R; Cong Y; Vasiliauskas EA; Ippoliti A; Elson CO; Rotter JI; Targan SR
Gut; 2009 Jan; 58(1):60-7. PubMed ID: 18832525
[TBL] [Abstract][Full Text] [Related]
2. Concordance in Anti-OmpC and Anti-I2 Indicate the Influence of Genetic Predisposition: Results of a European Study of Twins with Crohn's Disease.
Amcoff K; Joossens M; Pierik MJ; Jonkers D; Bohr J; Joossens S; Romberg-Camps M; Nyhlin N; Wickbom A; Rutgeerts PJ; Tysk C; Bodin L; Colombel JF; Vermeire S; Halfvarson J
J Crohns Colitis; 2016 Jun; 10(6):695-702. PubMed ID: 26818662
[TBL] [Abstract][Full Text] [Related]
3. Anti-flagellin (CBir1) phenotypic and genetic Crohn's disease associations.
Papadakis KA; Yang H; Ippoliti A; Mei L; Elson CO; Hershberg RM; Vasiliauskas EA; Fleshner PR; Abreu MT; Taylor K; Landers CJ; Rotter JI; Targan SR
Inflamm Bowel Dis; 2007 May; 13(5):524-30. PubMed ID: 17260364
[TBL] [Abstract][Full Text] [Related]
4. Antibodies to CBir1 flagellin define a unique response that is associated independently with complicated Crohn's disease.
Targan SR; Landers CJ; Yang H; Lodes MJ; Cong Y; Papadakis KA; Vasiliauskas E; Elson CO; Hershberg RM
Gastroenterology; 2005 Jun; 128(7):2020-8. PubMed ID: 15940634
[TBL] [Abstract][Full Text] [Related]
5. Serum immune responses predict rapid disease progression among children with Crohn's disease: immune responses predict disease progression.
Dubinsky MC; Lin YC; Dutridge D; Picornell Y; Landers CJ; Farrior S; Wrobel I; Quiros A; Vasiliauskas EA; Grill B; Israel D; Bahar R; Christie D; Wahbeh G; Silber G; Dallazadeh S; Shah P; Thomas D; Kelts D; Hershberg RM; Elson CO; Targan SR; Taylor KD; Rotter JI; Yang H;
Am J Gastroenterol; 2006 Feb; 101(2):360-7. PubMed ID: 16454844
[TBL] [Abstract][Full Text] [Related]
6. Sero-reactivity to microbial components in Crohn's disease is associated with disease severity and progression, but not NOD2/CARD15 genotype.
Arnott ID; Landers CJ; Nimmo EJ; Drummond HE; Smith BK; Targan SR; Satsangi J
Am J Gastroenterol; 2004 Dec; 99(12):2376-84. PubMed ID: 15571586
[TBL] [Abstract][Full Text] [Related]
7. Functional annotation of a novel NFKB1 promoter polymorphism that increases risk for ulcerative colitis.
Karban AS; Okazaki T; Panhuysen CI; Gallegos T; Potter JJ; Bailey-Wilson JE; Silverberg MS; Duerr RH; Cho JH; Gregersen PK; Wu Y; Achkar JP; Dassopoulos T; Mezey E; Bayless TM; Nouvet FJ; Brant SR
Hum Mol Genet; 2004 Jan; 13(1):35-45. PubMed ID: 14613970
[TBL] [Abstract][Full Text] [Related]
8. The clinical significance of antimicrobial serologic responses within an Irish Crohn's disease population.
O'Donnell S; O'Sullivan M; O'Morain CA; Ryan BM
Eur J Gastroenterol Hepatol; 2013 Dec; 25(12):1464-9. PubMed ID: 24047859
[TBL] [Abstract][Full Text] [Related]
9. Association of antibody responses to microbial antigens and complications of small bowel Crohn's disease.
Mow WS; Vasiliauskas EA; Lin YC; Fleshner PR; Papadakis KA; Taylor KD; Landers CJ; Abreu-Martin MT; Rotter JI; Yang H; Targan SR
Gastroenterology; 2004 Feb; 126(2):414-24. PubMed ID: 14762777
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial antibodies are associated with a Crohn's disease-like phenotype after ileal pouch-anal anastomosis.
Tyler AD; Milgrom R; Xu W; Stempak JM; Steinhart AH; McLeod RS; Greenberg GR; Cohen Z; Silverberg MS
Clin Gastroenterol Hepatol; 2012 May; 10(5):507-12.e1. PubMed ID: 21963956
[TBL] [Abstract][Full Text] [Related]
11. Serum antibodies to microbial antigens for Crohn's disease progression: a meta-analysis.
Xiong Y; Wang GZ; Zhou JQ; Xia BQ; Wang XY; Jiang B
Eur J Gastroenterol Hepatol; 2014 Jul; 26(7):733-42. PubMed ID: 24901819
[TBL] [Abstract][Full Text] [Related]
12. Anti-Saccharomyces cerevisiae mannan antibodies in familial Crohn's disease.
Sendid B; Quinton JF; Charrier G; Goulet O; Cortot A; Grandbastien B; Poulain D; Colombel JF
Am J Gastroenterol; 1998 Aug; 93(8):1306-10. PubMed ID: 9707056
[TBL] [Abstract][Full Text] [Related]
13. Elevated serum anti-flagellin antibodies implicate subclinical bowel inflammation in ankylosing spondylitis: an observational study.
Wallis D; Asaduzzaman A; Weisman M; Haroon N; Anton A; McGovern D; Targan S; Inman R
Arthritis Res Ther; 2013 Oct; 15(5):R166. PubMed ID: 24286190
[TBL] [Abstract][Full Text] [Related]
14. CARD15 polymorphisms are associated with anti-Saccharomyces cerevisiae antibodies in caucasian Crohn's disease patients.
Cruyssen BV; Peeters H; Hoffman IE; Laukens D; Coucke P; Marichal D; Cuvelier C; Remaut E; Veys EM; Mielants H; De Vos M; De Keyser F
Clin Exp Immunol; 2005 May; 140(2):354-9. PubMed ID: 15807862
[TBL] [Abstract][Full Text] [Related]
15. Anti-Microbial Antibody Response is Associated With Future Onset of Crohn's Disease Independent of Biomarkers of Altered Gut Barrier Function, Subclinical Inflammation, and Genetic Risk.
Lee SH; Turpin W; Espin-Garcia O; Raygoza Garay JA; Smith MI; Leibovitzh H; Goethel A; Turner D; Mack D; Deslandres C; Cino M; Aumais G; Panaccione R; Jacobson K; Bitton A; Steinhart AH; Huynh HQ; Princen F; Moayyedi P; Griffiths AM; Silverberg MS; Paterson AD; Xu W; Croitoru K;
Gastroenterology; 2021 Nov; 161(5):1540-1551. PubMed ID: 34293299
[TBL] [Abstract][Full Text] [Related]
16. The impact of intestinal resection on serum levels of anti-Saccharomyces cerevisiae antibodies (ASCA) in patients with Crohn's disease.
Eser A; Papay P; Primas C; Pernicka E; Harrer M; Dejaco C; Novacek G; Lichtenberger C; Angelberger S; Kazemi L; Mikulits A; Vogelsang H; Reinisch W
Aliment Pharmacol Ther; 2012 Jan; 35(2):292-9. PubMed ID: 22146122
[TBL] [Abstract][Full Text] [Related]
17. Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn's disease and ulcerative colitis: diagnostic value and correlation with disease phenotype.
Zholudev A; Zurakowski D; Young W; Leichtner A; Bousvaros A
Am J Gastroenterol; 2004 Nov; 99(11):2235-41. PubMed ID: 15555007
[TBL] [Abstract][Full Text] [Related]
18. [Relevance of serologic studies in inflammatory bowel diseases].
Papp M; Altorjay I; Lakatos PL
Orv Hetil; 2007 May; 148(19):887-96. PubMed ID: 17478404
[TBL] [Abstract][Full Text] [Related]
19. Higher titers of anti-Saccharomyces cerevisiae antibodies IgA and IgG are associated with more aggressive phenotypes in Romanian patients with Crohn's disease.
Gologan S; Iacob R; Preda C; Vadan R; Cotruta B; Catuneanu AM; Iacob S; Constantinescu I; Gheorghe L; Iobagiu S; Gheorghe C; Diculescu M
J Gastrointestin Liver Dis; 2012 Mar; 21(1):39-44. PubMed ID: 22457858
[TBL] [Abstract][Full Text] [Related]
20. Inflammatory bowel disease serologies in ankylosing spondylitis patients: a pilot study.
Mundwiler ML; Mei L; Landers CJ; Reveille JD; Targan S; Weisman MH
Arthritis Res Ther; 2009; 11(6):R177. PubMed ID: 19930665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
